Back
SpringWorks Therapeutics Stock Price Chart
Sponsored
SWTX
Sponsored
Access "King of the Quants" Stock Rating System FREE!
[Claim Your 3 Free Grades Now]
Sell
25
SWTX
SpringWorks Therapeutics
Last Price:
$35.00
Seasonality Move:
-12.64%
7 Day Trial
ALL ACCESS PASS
$
7
Free Access to "King of the Quants" Stock Rating System
[Claim Your 3 Free Grades Now]-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SWTX is experiencing slight buying pressure.
SpringWorks Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.63 | Sell |
20-day SMA: | 36.9 | Sell |
50-day SMA: | 37.67 | Sell |
200-day SMA: | 38.01 | Sell |
8-day EMA: | 36.11 | Buy |
20-day EMA: | 36.95 | Sell |
50-day EMA: | 36.91 | Sell |
200-day EMA: | 36.92 | Sell |
SpringWorks Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.57 | Sell |
Relative Strength Index (14 RSI): | 48.16 | Sell |
Chaikin Money Flow: | 212961 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (34.81 - 39.33) | Sell |
Bollinger Bands (100): | (31.78 - 39.84) | Buy |
SpringWorks Therapeutics Technical Analysis
Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for SpringWorks Therapeutics Stock
Is SpringWorks Therapeutics Stock a Buy?
-
SpringWorks Therapeutics share price is 36.35 while SWTX 8-day simple moving average is 36.63, which is a Sell signal.
-
The stock price of SWTX is 36.35 while SpringWorks Therapeutics 20-day SMA is 36.90, which makes it a Sell.
-
SpringWorks Therapeutics 50-day simple moving average is 37.67 while SWTX share price is 36.35, making it a Sell technically.
-
SWTX stock price is 36.35 and SpringWorks Therapeutics 200-day simple moving average is 38.01, creating a Sell signal.
SWTX Technical Analysis vs Fundamental Analysis
Sell
25
SpringWorks Therapeutics (SWTX)
is a Sell
Is SpringWorks Therapeutics a Buy or a Sell?
-
SpringWorks Therapeutics stock is rated a SellThe current SpringWorks Therapeutics [SWTX] share price is $36.35. The Score for SWTX is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
SpringWorks Therapeutics Stock Info
Market Cap:
2.7B
Price in USD:
36.35
Share Volume:
1.3M
SpringWorks Therapeutics 52-Week Range
52-Week High:
53.92
52-Week Low:
28.21
Sell
25
SpringWorks Therapeutics (SWTX)
is a Sell
SpringWorks Therapeutics Share Price Forecast
-
What is the SpringWorks Therapeutics stock price today?The SpringWorks Therapeutics stock price is 36.35 USD today.
-
Will SWTX stock go up or go down?SpringWorks Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is SpringWorks Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, SpringWorks Therapeutics is overvalued.
Is SpringWorks Therapeutics Stock a Buy?
-
SpringWorks Therapeutics share price is 36.35 while SWTX 8-day exponential moving average is 36.11, which is a Buy signal.
-
The stock price of SWTX is 36.35 while SpringWorks Therapeutics 20-day EMA is 36.95, which makes it a Sell.
-
SpringWorks Therapeutics 50-day exponential moving average is 36.91 while SWTX share price is 36.35, making it a Sell technically.
-
SWTX stock price is 36.35 and SpringWorks Therapeutics 200-day simple moving average is 36.92, creating a Sell signal.
Fundamental Analysis of SpringWorks Therapeutics
Is SpringWorks Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.12 per share, and an increase next year of $1.33 per share.
Technical Analysis of SpringWorks Therapeutics
Should I short SpringWorks Therapeutics stock?
-
SWTX Moving Average Covergence Divergence (MACD) indicator is -0.57, suggesting SpringWorks Therapeutics is a Sell
-
SpringWorks Therapeutics Relative Strength Index (RSI) is 48.16, which suggest SpringWorks Therapeutics is oversold
-
The Bollinger Bands (25) for SpringWorks Therapeutics is (34.81 - 39.33), which suggest SpringWorks Therapeutics is a Buy
-
The Bollinger Bands (100) for SpringWorks Therapeutics is (31.78 - 39.84), which suggest SpringWorks Therapeutics is a Buy
* SpringWorks Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.